Search results
Kymera reports promising Phase 1 results for KT-333 cancer drug By Investing.com
Investing.com· 6 hours agoThe ongoing trial assesses the safety, tolerability, and efficacy of KT-333 in adults with relapsed...
Jaguars sign second tryout WR, place OL on injured reserve
Jaguars Wire via Yahoo Sports· 3 hours agoHe appeared in one game. Undrafted out of Middle Tennessee in 2019, Brewer originally signed with...
Gen X is on track to have more cancer than baby boomers—and these 9 cancers are to blame
Fortune via AOL· 5 hours agoGen X women, the research found, will see significant increases over baby boomer women of the...
Los Huracanes Del Norte fills State Fair concert slot
Grand Island Independent· 4 hours agoLos Huracanes Del Norte will fill the Nebraska State Fair concert slot left vacant by the tour...
Woman pleads guilty to theft charge for faking cancer, taking donations
KKCO Grand Junction CO· 14 hours agoA woman from Toledo, Ohio, has been convicted of faking cancer and taking donations for treatment....
Lantern Pharma secures Japan patent for cancer drug By Investing.com
Investing.com· 2 days agoThe Japan Patent Office issued the certificate for the molecule, which is currently in a Phase 1...
Affimed N.V. (NASDAQ:AFMD) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoAffimed N.V. (NASDAQ:AFMD) Q1 2024 Earnings Call Transcript June 12, 2024 Affimed N.V. beats...
Breast cancer risk assessment tool: What it can and cannot tell you
Medical News Today· 2 days agoThe Breast Cancer Risk Assessment Tool (BCRAT) can estimate a female’s risk of developing breast...
Research pair finds Gen X people more susceptible to many types of cancers than prior generations
Medical Xpress· 2 days agoA pair of biostatisticians at the U.S. National Cancer Institute, has found that members of...
Earnings call: Affimed reports positive clinical data in Q1 2024 update
Investing.com· 3 days agoAffimed N.V. ( NASDAQ : NASDAQ: AFMD ), a clinical-stage biopharmaceutical company, has announced...